Home›Companies›Biotech & Pharma›Pulmotherapeutics

Pulmotherapeutics Inc

Updated Oct 27, 2026·Latest SEC filing Apr 14, 2025·Suggest an edit

About Pulmotherapeutics

Pulmotherapeutics is a private company based in Tyler, Texas, incorporated in 2024 in Delaware. It has reported $500,000 raised in one offering on Form D since April 2025. Its chief executive is Nagarjun Konduru Venkata.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 27, 2025Apr 14, 2025$500,000target not set3$166KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Pulmotherapeutics's Form D filed Apr 14, 2025.

NV
Nagarjun Konduru Venkata
Chief Executive Officer and director

Sources

  1. SECPulmotherapeutics Inc filing history